Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

UBS Lux Equity Fund - Biotech USD

+ Add to Watchlist

UBFC:GR

581.6100 EUR 2.1500 0.37%

As of 13:59:53 ET on 03/26/2015.

Snapshot for UBS Lux Equity Fund - Biotech USD (UBFC)

Open: 565.2900 High - Low: 581.6100 - 550.8300 Primary Exchange: Berlin
Volume: 290 52-Week Range: 267.4000 - 648.7600 Beta vs NSESWRLD: 1.0097

ETF Chart for UBFC

No chart data available.
  • UBFC:GR 570.4500
  • 1D
  • 1M
  • 1Y
579.4600
Interactive UBFC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UBFC

UBS Lux Equity Fund - Biotech USD is an open-end investment fund incorporated in Luxembourg. The Fund's objective is medium- to long-term capital growth. The Fund invests globally in equities of companies engaged in research, product development, product manufacturing and distribution in the biotechnology sector.

Inception Date: Telephone: 352-44-10-10-1 Tel
Managers: ANGUS MUIRHEAD / NATHALIE LOTSCHER PETRUS
Web Site: www.ubs.com

Fundamentals for UBFC

NAV (on 2010-07-14) 162.7800
Assets (M) (on 2015-03-25) 1,845.6750
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for UBFC

No dividends reported

Performance for UBFC

1-Month +6.20% 1-Year +82.50%
3-Month +29.99% 3-Year +52.83%
Year To Date +24.81% 5-Year +31.95%
Expense Ratio 2.08

Top Fund Holdings for UBFC

Filing Date: 01/31/2015
Name Position Value % of Total
Biogen Inc 440,700 171,502,812 10.285%
Gilead Sciences Inc 1,538,500 161,280,955 9.672%
Amgen Inc 814,714 124,048,354 7.439%
Celgene Corp 966,620 115,182,439 6.907%
Alexion Pharmaceuticals Inc 430,800 78,939,792 4.734%
BioMarin Pharmaceutical Inc 812,100 78,903,636 4.732%
Vertex Pharmaceuticals Inc 653,200 71,943,448 4.314%
Alkermes PLC 961,893 69,496,769 4.168%
Medivation Inc 582,600 63,398,532 3.802%
Incyte Corp 608,200 48,479,622 2.907%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil